Skip to main content
Caplight Logo









AssayMe

AssayMe

Private
Santa Clarita, CaliforniaHealthcare & Life Scienceshttps://assayme.com

Last Round

Seed

Jun 12, 2023

Total Funding Raised

$1.5M

Company Overview

AssayMe operates in Healthcare & Life Sciences and is based in Santa Clarita, California. Its latest recorded funding round was a Seed round in June 2023.

AssayMe is a healthtech company that provides a personal wellness and health assistant platform, offering at-home urine test kits and AI-powered mobile application analysis for health monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Computer Vision, D2C Brands, Sports & Fitness

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AssayMe Comparables

Compare AssayMe with similar companies based on industry and business-model similarity.

AssayMe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivoo
86%
Vessel Health
85%
myDOXA
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AssayMe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 12, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Nik Plotnikov

Founder and CEO

Founding Team

For institutional investors. Book with your work email.

AssayMe Investors

Notable investors and investment history

AssayMe investors
InvestorRounds
Goodwater CapitalSeed
First Round CapitalSeed
FJ LabsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 12, 2023

    $2M round led by Goodwater Capital

Book a demo to see all signals

For institutional investors. Book with your work email.

AssayMe Filings

Explore SEC and related filing metadata, where available.

AssayMe filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AssayMe's valuation, stock price, and market status.

Is AssayMe a public or private company?

AssayMe is a private company.

What is the current stock price of AssayMe?

AssayMe is a private company, so its shares have no public market price. Caplight tracks AssayMe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AssayMe worth (valuation)?

Valuation information for AssayMe is not publicly available.

Can I buy AssayMe stock?

AssayMe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AssayMe's last funding round?

AssayMe's most recent funding round was Seed on June 12, 2023.

Who are the main investors in AssayMe?

Key investors in AssayMe include Goodwater Capital.

Will AssayMe IPO soon?

No public IPO plans have been announced for AssayMe.

How can I track AssayMe secondary market activity?

Caplight tracks bids, offers, and trades in AssayMe's shares on secondary markets.

Firmographic Details

HeadquartersSanta Clarita, California
Employee Range2
Year Founded2019
Last FundingJun 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?